]>
IRCT20170818035762N3 IRCT 2020-05-30 Mazandaran University of Medical Sciences betamethasone valerate on post-cryotherapy The effects of topical betamethasone valerate on post-cryotherapy inflammation in cutaneous wart treatment 2019-04-04 anticipated 40 Complete https://irct.ir/trial/46964 interventional Randomization: Not randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Blinding description: we use medicine on one limb and use placebo. on another limb. executor of plan and Patient don't know which limb take the medicine. 2-3 skin wart. Intervention 1: Intervention group: In our study, patients with skin warts in two different organs were included. The first intervention group was given one of the organs with betamethasone valrate after cryotherapy. Intervention 2: Control group: Control group: In our study, patients enter the study who have skin warts in two different organs. In the second intervention group, we used placebo on an organ that did not use betamethasone valrate. Yes - There is a plan to make this available What will be shared: Only part of the data, such as information about the main outcome or the like, can be shared When: Start the access period 6 months after printing the results To whom: Researchers working in academic and scientific institutions Conditions: Researchers working in academic and scientific institutions Where to obtain: Email to: A.kazeminejad@mazums.ac.ir How to obtain: After communicating with the email if available, data and results will be available Comments:
public Armaghan Kazeminezhad
Mazandaran University of Medical Sciences ,Sari , Mazandaran
sari Iran (Islamic Republic of) ۴۸۱۵۷۳۳۹۷۱ +98 11 4221 8021 a.kazeminejad@mazums.ac.ir Mazandaran University of Medical Sciences scientific Dr.ArMarghan Kazeminejad
Headquarters of Mazandaran University of Medical Sciences. At the beginning of Valiasr Highway.Sari
Sari Iran (Islamic Republic of) 4815733971 +98 11 3304 4001 A.kazeminejad@mazums.ac.ir Mazandaran University of Medical Sciences Iran (Islamic Republic of) Patients with skin wart who are diagnosed by a dermatologist clinically or pathologically and have cryotherapy indications. Patients over 2 years of age They have a conscious consent to enter the study the maximum number of warts is up to 20 2 years no limit Both pregnant and lactating women People treated with systemic medications that interfere with wound healing or immuno suppressive drugs Patients who have contraindications for cryotherapy Patients who have used topical medications other than emollients in the past month People who are allergic to betamethasone or topical steroids Patients with wound healing disorders such as diabetes Distributed and resistant warts that need further treatment B07 Viral warts Treatment - Drugs Placebo Intervention group: In our study, patients with skin warts in two different organs were included. The first intervention group was given one of the organs with betamethasone valrate after cryotherapy. Control group: Control group: In our study, patients enter the study who have skin warts in two different organs. In the second intervention group, we used placebo on an organ that did not use betamethasone valrate Tolerance of pain to cryotherapy treatment. Timepoint: Day 1,7 and 14. Method of measurement: Vas scale. Illness severity. Timepoint: At the beginning of the study. Method of measurement: Based on the number of warts. Duration of illness. Timepoint: At the beginning of the study. Method of measurement: Number of days before starting treatment. Eritrea. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination. Blisters. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination. Scar. Timepoint: The second, eighth and fifteenth day after starting treatment. Method of measurement: Based on the examination. Mazandaran University of Medical Sciences Approved 2019-02-16 Ethics committee of mazandaran University of Medical Sciences Central Headquarters of Mazandaran University of Medical Sciences,at the beginning of Valiasr Highway,Joibar Three Ways,Imam Square, Sari sari Mazandaran Iran (Islamic Republic of)